Open Access iconOpen Access

ARTICLE

crossmark

Piperlongumine in combination with EGFR tyrosine kinase inhibitors for the treatment of lung cancer cells

SHAIL RAKESH MODI, TERRICK ANDEY*

Department of Pharmaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences, Worcester, MA 01608, USA

* Corresponding Author: TERRICK ANDEY. Email: email

TSP_OR_53972.pdf

  • 894

    View

  • 206

    Download

  • 0

    Like

Share Link